Decision on Covaxin's emergency use listing in 4-6 weeks: WHO
Jul 11, 2021, at 02:11 am
New Delhi/IBNS: The World Health Organisation (WHO) will take a decision on emergency use approval for Bharat Biotech's Covaxin in the next four to six weeks, Soumya Swaminathan, the UN health body's chief scientist has said.
India reports 39,796 COVID-19 cases, 723 deaths in 24 hours
Jul 05, 2021, at 04:34 pm
New Delhi/IBNS: India, which is recovering from the second wave of COVID-19, on Monday reported over 39,000 new infections besides 723 deaths apparently due to the virus.
Covaxin's efficacy result will help getting WHO's approval : Govt expert body chief
Jul 04, 2021, at 02:04 am
New Delhi/IBNS: India-made Covaxin's recently published result on efficacy will help the vaccine in getting World Health Organisation’s (WHO) emergency approval, the chairperson of National Technical Advisory Group on Immunisation in India (NTAGI), Dr NK Arora said on Saturday.
Covaxin overall 77.8% effective against COVID-19, claims Bharat Biotech
Jul 03, 2021, at 06:54 pm
New Delhi/IBNS: Hyderabad-based biotechnology company Bharat Biotech has claimed its anti-COVID-19 vaccine, Covaxin, is 77.8% effective against the deadly virus.
Bharat Biotech says COVAXIN records 77.8 percent effectiveness against COVID-19
Jul 03, 2021, at 02:30 pm
Hyderabad: Bharat Biotech on Saturday claimed its created COVID-19 vaccine COVAXIN has shown 77.8 per cent effectiveness against the virus.
India reports over 48,000 COVID-19 cases, 1,005 deaths in 24 hours
Jul 01, 2021, at 04:29 pm
New Delhi/IBNS: In a slight increase in daily cases, India on Thursday reported 48,786 new COVID-19 infections besides registering 1,005 deaths apparently due to the virus in the last 24 hours.
Jun 30, 2021, at 02:38 pm
Washington: A study conducted by the US' National Institute of Health has said India's COVAXIN, which was developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, neutralises both Alpha and Delta variants of COVID-19.
Phase 3 trial data reveal Covaxin 77.8 pc effective against Covid19: Report
Jun 22, 2021, at 09:50 pm
New Delhi/IBNS: Indigenously made Covid-19 jab, Bharat Biotech's Covaxin is 77.8 per cent effective in protecting against the deadly infection, according to data released from phase 3 trials conducted on 25,800 participants across India, according to media reports.
COVID-19 vaccine: Bharat Biotech submits Covaxin phase 3 trial data to DGCI, say reports
Jun 22, 2021, at 07:22 pm
New Delhi/IBNS: Hyderabad-based drug manufacturer Bharat Biotech has submitted the phase three clinical trial data of its anti-COVID-19 vaccine, Covaxin, to the Drug Controller General of India (DGCI), media reports said.
AIIMS Delhi to start screening 6-12 yrs children for Covaxin trial from Tuesday
Jun 15, 2021, at 05:57 am
New Delhi/IBNS: The All India Institute of Medical Sciences (AIIMS), New Delhi will begin the selection process of children in the age group of 6-12 years for the clinical trials of Bharat Biotech's Covaxin on Tuesday, said Dr Sanjay Rai, professor at the Centre for Community Medicine at AIIMS Delhi, said a media report.
Bharat Biotech to conduct clinical trials for Covaxin in US, Canada
Jun 14, 2021, at 02:31 am
Hyderabad/IBNS: Bharat Biotech will conduct clinical trials for Covaxin in United States and Canada as its US partner Ocugen has said that it will apply for a full licence in the United States for the India-made vaccine.
Covaxin: Bharat Biotech shares full data of all research studies
Jun 12, 2021, at 11:14 pm
Hyderabad/UNI: Demonstrating its scientific commitment to data generation and data transparency, Bharat Biotech shared full data of all research studies of its Covaxin, India’s first indigenous COVID-19 vaccine.
US FDA denies India’s Covaxin emergency use approval; seeks additional clinical trial data
Jun 12, 2021, at 05:13 am
Hyderabad/UNI:India’s indigenous Covid vaccine ‘Covaxin’ developed by Hyderabad-based Bharat Biotech (BB), will be delayed to launch in the US market as US Food and Drug Administration (FDA) asked ‘Ocugen Inc ‘ the US partner of the BB, to pursue a biological Applications (BLA) path for ‘Covaxin,’ which is full approval.
Covid-19: clinical trials using Covaxin on children begins
Jun 11, 2021, at 02:38 am
Bengaluru/UNI: In all 30 children, aged 12-18, were administered Covaxin at Mysuru Medical College and Research Institute (MMCRI) as part of Hyderabad-based pharmaceutical major Bharat Biotech's clinical trials.
India reports highest COVID-19 deaths in 24 hours
Jun 10, 2021, at 06:17 pm
New Delhi/IBNS: India, which is slowly recovering from the second wave of coronavirus, on Thursday witnessed a big jump in daily COVID-19 toll as it recorded the highest number of deaths due to the contagion in the last 24 hours.
Delhi receives major supply of Covishied, Covaxin doses
Jun 10, 2021, at 02:00 am
Delhi/IBNS: Amid shortage of vaccines that reportedly forced the Delhi government to stop inoculation drive for 18-44 age group, major supplies of both Covishield and Covaxin reached the national capital Wednesday.
Delta variant of Covid can infect even after Covishield, Covaxin jabs: AIIMS study
Jun 09, 2021, at 10:19 pm
New Delhi/IBNS: The 'delta' variant of COVID-19, the version first detected in India in October last year, can infect people even after they have received both jabs of the Covaxin or Covishield vaccines, new studies, done separately by AIIMS (Delhi) and the National Centre for Disease Control (NCDC), revealed.
May 26, 2021, at 05:44 am
Hyderabad/IBNS: Amid travel fears that students receiving Covaxin may not be allowed in many countries as the vaccine is not listed, Hyderabad-based pharma major Bharat Biotech on Tuesday said regulatory approvals for its indigenously developed Covid-19 vaccine are in process in more than 60 countries including the US, Brazil and Hungary.
Coronavirus: Karnataka receives 3 lakh Covishield doses from Centre
May 25, 2021, at 11:15 pm
Bengaluru/UNI: Karnataka Minister for Health and Medical Education Dr K Sudhakar has said that the State has received 3 lakh Covishield doses from the Centre on Tuesday.
Pediatric trials of Covaxin likely from Jun 1: Dr Raches Ella
May 23, 2021, at 09:19 pm
Hyderabad/UNI: Dr Raches Ella, Head-Business Development & International Advocacy of Bharath Biotech said that the company has received permission to carry out pediatric trials of the Covaxin and it may commence trials from June 1.
Covishield vs Covaxin: Which to choose? Govt says both vaccines work well
May 21, 2021, at 07:19 am
New Delhi/IBNS: The government on Thursday said Bharat Biotech's Covaxin and Serum Institute of India produced Covishield cannot be compared with each other, scientifically, to choose one over another.
Bharat Biotech ramps up Covaxin production by 200 million doses
May 21, 2021, at 05:00 am
New Delhi/IBNS: Bharat Biotech on Thursday said it is gearing up to increase manufacturing capacity of Covaxin by 200 million doses per year.
Bharat Biotech to start Covaxin trials in 2-18 age grp in next 10-12 days: Niti Aayog member
May 19, 2021, at 02:13 am
New Delhi/IBNS: Bharat Biotech will launch the phase II and III clinical trials for Covaxin in children between the ages of 2 to 18 years in the next 10-12 days, Dr VK Paul, member (health) of Niti Aayog, said on Tuesday.
Centre, Bharat Biotech invite vaccine makers to manufacture Covaxin to scale up production
May 14, 2021, at 04:21 am
New Delhi/IBNS: The central government and Hyderabad-based pharmaceutical company Bharat Biotech are willing to invite other companies which want to produce Covaxin to help meet the shortage in production, a top government advisor said on Thursday.
Indian drug regulator DGCI clears Covaxin phase 2, 3 clinical trials for children
May 13, 2021, at 05:08 pm
New Delhi/IBNS: India's drug regulator body has cleared the second and third phase of clinical trials of indigenous anti-Covid-19 vaccine, Covaxin, for children, media reports said.
India reports 3.62 lakh new Covid-19 cases, over 4,000 deaths in 24 hours
May 13, 2021, at 04:46 pm
New Delhi/IBNS: More than 3.62 lakh new Covid-19 cases and over 4,000 deaths apparently due to the virus were reported in massively Coronavirus-hit Asian country India on Thursday.
No Covaxin doses for 18-44 years in Delhi from tomorrow
May 13, 2021, at 05:21 am
New Delhi/IBNS: People between the age group of 18-44 years will not get Covaxin doses in Delhi from Thursday as there is no stock of the Bharat Biotech developed vaccine left in the national capital.
Covaxin supplied to 18 states directly since May 1: Bharat Biotech
May 12, 2021, at 05:24 am
New Delhi/IBNS: Vaccine maker Bharat Biotech on Tuesday informed that it has directly supplied Covaxin to 18 states since May 1.
Bharat Biotech cuts down Covaxin's price for states
Apr 30, 2021, at 01:55 am
Hyderabad/IBNS: Bharat Biotech has reduced the price of Covaxin from Rs 600 per dose to Rs 400 for the state governments in view of the challenges faced by the already overstretched health system, the company said on Thursday.
Apr 29, 2021, at 05:08 am
New Delhi/IBNS: Covaxin, developed by Hyderabad-based Bharat Biotech, ICMR and National Institue of Virology, has been found to protect against the B.1.617 variant or the Indian double mutant strain, said White House Chief Medical Adviser Anthony Fauci on Tuesday.